A carregar...
Targeted alpha therapy of mCRPC: Dosimetry estimate of (213)Bismuth-PSMA-617
PURPOSE: PSMA-617 is a small molecule targeting the prostate-specific membrane antigen (PSMA). In this work, we estimate the radiation dosimetry for this ligand labeled with the alpha-emitter (213)Bi. METHODS: Three patients with metastatic prostate cancer underwent PET scans 0.1 h, 1 h, 2 h, 3 h, 4...
Na minha lista:
| Publicado no: | Eur J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700223/ https://ncbi.nlm.nih.gov/pubmed/28891033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3817-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|